Kohjin Bio Co., Ltd.
Standard fundamentals
P/E, P/B, ROE, debt, growth and more (14)
Kohjin Bio Co., Ltd. owes ¥0.33 for every ¥1 it owns. Net profit fell 68% in the year to Mar 2026, and shrank 33% a year on average over 3 years.
Compared with Healthcare companies in Japan · latest annual results Mar 2026.
P/E ratio
31.5Investors pay ¥31.5 for every ¥1 of Kohjin Bio Co., Ltd.'s yearly profit, higher than 85% of Healthcare companies in Japan.
P/B ratio
0.67The share price is 0.67 times Kohjin Bio Co., Ltd.'s book value per share, lower than 92% of Healthcare companies in Japan.
Market cap
¥4.0 BThe total market value of all of Kohjin Bio Co., Ltd.'s shares at today's price (share price × number of shares), smaller than 82% of Healthcare companies in Japan. PosiCap size class: Micro Cap.
Net worth (book value)
¥5.9 BWhat Kohjin Bio Co., Ltd. would have left on paper if it sold everything it owns and paid everything it owes, from its latest balance sheet (31 Mar 2026).
Book value per share
¥1,163Net worth divided by the number of shares. The share price of ¥781.00 is 0.7 times this, which is the P/B above.
Return on equity (ROE)
2.2%Kohjin Bio Co., Ltd. earned 2.2% on its shareholders' money over the last year, lower than 69% of Healthcare companies in Japan.
Owes vs Owns
0.33×Kohjin Bio Co., Ltd. owes ¥0.33 for every ¥1 it owns (low).
Dividend yield
1.27%Kohjin Bio Co., Ltd. pays 1.27% of its share price as dividends a year, lower than 88% of dividend-paying Healthcare companies in Japan.
Revenue growth
-5%Revenue fell 5% in the year to Mar 2026, and grew 1% a year on average over 3 years.
Profit growth
-68%Net profit fell 68% in the year to Mar 2026, and shrank 33% a year on average over 3 years.
Profit margin
5.1%Kohjin Bio Co., Ltd. keeps ¥5 of every ¥100 of revenue as net profit.
Cash quality
2.8×Cash from Kohjin Bio Co., Ltd.'s business was 2.8× its reported profit in the year to Mar 2026 — its profit turned into cash.
Interest cover
9.0×Kohjin Bio Co., Ltd.'s operating profit covered its interest costs 9.0 times in the year to Mar 2026.
Cash vs debt
Net cashKohjin Bio Co., Ltd. held ¥295 M more cash than debt (net cash) at Mar 2026.
Questions
What is Kohjin Bio Co., Ltd.'s P/E ratio?
Investors pay ¥31.5 for every ¥1 of Kohjin Bio Co., Ltd.'s yearly profit, higher than 85% of Healthcare companies in Japan.
How is P/B calculated on PositoAI?
P/B is market cap divided by net worth from the latest balance sheet. For Kohjin Bio Co., Ltd.: ¥4.0 B ÷ ¥5.9 B (31 Mar 2026) = 0.7.
What is Kohjin Bio Co., Ltd.'s return on equity?
Kohjin Bio Co., Ltd. earned 2.2% on its shareholders' money over the last year, lower than 69% of Healthcare companies in Japan.
How much does Kohjin Bio Co., Ltd. owe compared with what it owns?
Kohjin Bio Co., Ltd. owes ¥0.33 for every ¥1 it owns (low).
Does Kohjin Bio Co., Ltd. pay a dividend?
Yes. Kohjin Bio Co., Ltd. pays 1.27% of its share price as dividends a year, lower than 88% of dividend-paying Healthcare companies in Japan.
Is Kohjin Bio Co., Ltd.'s revenue growing?
Revenue fell 5% in the year to Mar 2026, and grew 1% a year on average over 3 years.
Figures from the company's yearly results and PositoAI's own data. Full tables are on the Go Deep tab. What each figure means. PositoAI is for research and education only and is not investment advice.